FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3929011000001103: Myleran 2mg tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18050101000001119 Myleran 2mg tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
69182801000001118 Myleran 2mg tablets (Aspen Pharma Trading Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Myleran 2mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Is a Product containing precisely busulfan 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Has excipient Lactose false Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Has active ingredient Busulfan false Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Is a Myleran true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Has specific active ingredient Busulfan true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Myleran 2mg tablets (GlaxoSmithKline) 25 tablet Is pack of False Myleran 2mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Myleran 2mg tablets (GlaxoSmithKline) 25 tablet Has AMP True Myleran 2mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start